This activation results in the deposition of iC3b on tumor cells, which in turn facilitates engagement of immune effector cells via CR3 and the Fc region of the immunoglobulin G receptor IIa (FcγRIIA). This evidence concerns the gene CRIPTO3 and neoplasm.